Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice

Detalles Bibliográficos
Autores principales: Gallo, Linda A., Ward, Micheal S., Fotheringham, Amelia K., Zhuang, Aowen, Borg, Danielle J., Flemming, Nicole B., Harvie, Ben M., Kinneally, Toni L., Yeh, Shang-Ming, McCarthy, Domenica A., Koepsell, Hermann, Vallon, Volker, Pollock, Carol, Panchapakesan, Usha, Forbes, Josephine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936511/
https://www.ncbi.nlm.nih.gov/pubmed/27389496
http://dx.doi.org/10.1038/srep28124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936511/
https://www.ncbi.nlm.nih.gov/pubmed/27389496
http://dx.doi.org/10.1038/srep28124

Ejemplares similares